PolyPeptide Group Investor Relations Material

PolyPeptide Group AG is a leading contract development and manufacturing organization (CDMO) specializing in the production of peptides and related molecules. The company provides services across the entire development spectrum, from initial peptide synthesis to commercial-scale manufacturing. PolyPeptide supports pharmaceutical and biotech companies with both proprietary and generic Good Manufacturing Practice (GMP)-grade peptides used in approved pharmaceutical products, drugs in clinical development, and in generic products. Additionally, it manufactures a variety of peptides used in cosmetic applications. The company is headquartered in Baar, Canton of Zug, Switzerland, and its shares are listed on the stock exchange.